List of Balcoltra drug patents
Balcoltra is owned by Avion Pharms.
Balcoltra contains Ethinyl Estradiol; Levonorgestrel.
Balcoltra has a total of 1 drug patent out of which 0 drug patents have expired.
Balcoltra was authorised for market use on 09 January, 2018.
Balcoltra is available in tablet;oral dosage forms.
Balcoltra can be used as administration of ferrous bisglycinate tablets.
The generics of Balcoltra are possible to be released after 01 June, 2027.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7838042 | AVION PHARMS | Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions |
Jun, 2027
(3 years from now) | |
Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient
Market Authorisation Date: 09 January, 2018
Treatment: Administration of ferrous bisglycinate tablets
Dosage: TABLET;ORAL
BALCOLTRA family patents
2
United States
1
Germany
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic